Proposed sale of 2,000 United Therapeutics shares (UTHR) via option exercise
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
United Therapeutics reported a Form 144 notice proposing the sale of 2,000 common shares. The filing lists the proposed sale date as 03/04/2026, arising from a stock option exercise with proceeds to be received in cash. The record shows a prior sale of 910 shares on 12/18/2025 for $455,533.17.
Positive
- None.
Negative
- None.
FAQ
What does UTHR's Form 144 report?
It reports a proposed sale of 2,000 common shares on 03/04/2026. The filing states the sale arises from a stock option exercise and that proceeds will be received in cash.
Who is the reported selling party in the UTHR Form 144?
The filing lists Tommy Thompson at the provided address as the filer. Broker information names Morgan Stanley Smith Barney LLC, with execution details and the 03/04/2026 sale date shown.
Does the filing show recent prior sales by the same filer?
Yes — it discloses a prior sale of 910 common shares on 12/18/2025. That past sale is shown with a value of $455,533.17 in the excerpt.
What broker is listed for the proposed UTHR sale?
Morgan Stanley Smith Barney LLC is named in the securities and broker lines. The broker address and related execution details appear in the filing excerpt.